Inhibition of Hsp90 in the spinal cord enhances the antinociceptive effects of morphine by activating an ERK-RSK pathway
AuthorDuron, David I
Barker, Natalie K
Blagg, Brian S J
Langlais, Paul R
Streicher, John M
AffiliationUniv Arizona, Coll Med, Dept Pharmacol
Univ Arizona, Coll Med, Dept Med, Div Endocrinol
MetadataShow full item record
PublisherAMER ASSOC ADVANCEMENT SCIENCE
CitationDuron, D. I., Lei, W., Barker, N. K., Stine, C., Mishra, S., Blagg, B. S., ... & Streicher, J. M. (2020). Inhibition of Hsp90 in the spinal cord enhances the antinociceptive effects of morphine by activating an ERK-RSK pathway. Science signaling, 13(630).
RightsCopyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at email@example.com.
AbstractMorphine and other opioids are commonly used to treat pain despite their numerous adverse side effects. Modulating mu-opioid receptor (MOR) signaling is one way to potentially improve opioid therapy. In mice, the chaperone protein Hsp90 mediates MOR signaling within the brain. Here, we found that inhibiting Hsp90 specifically in the spinal cord enhanced the antinociceptive effects of morphine in mice. Intrathecal, but not systemic, administration of the Hsp90 inhibitors 17-AAG or KU-32 amplified the effects of morphine in suppressing sensitivity to both thermal and mechanical stimuli in mice. Hsp90 inhibition enabled opioid-induced phosphorylation of the kinase ERK and increased abundance of the kinase RSK in the dorsal horns of the spinal cord, which are heavily populated with primary afferent sensory neurons. The additive effects of Hsp90 inhibition were abolished upon intrathecal inhibition of ERK, RSK, or protein synthesis. This mechanism downstream of MOR, localized to the spinal cord and repressed by Hsp90, may potentially be used to enhance the efficacy and presumably decrease the side effects of opioid therapy.
VersionFinal accepted manuscript
- Heat-shock protein 90 (Hsp90) promotes opioid-induced anti-nociception by an ERK mitogen-activated protein kinase (MAPK) mechanism in mouse brain.
- Authors: Lei W, Mullen N, McCarthy S, Brann C, Richard P, Cormier J, Edwards K, Bilsky EJ, Streicher JM
- Issue date: 2017 Jun 23
- Antinociceptive effects of morphine and naloxone in mu-opioid receptor knockout mice transfected with the MORS196A gene.
- Authors: Chen SL, Ma HI, Han JM, Lu RB, Tao PL, Law PY, Loh HH
- Issue date: 2010 Apr 20
- Spinal mu-opioid receptor-expressing dorsal horn neurons: role in nociception and morphine antinociception.
- Authors: Kline RH 4th, Wiley RG
- Issue date: 2008 Jan 23
- Heat shock protein 90 inhibitors block the antinociceptive effects of opioids in mouse chemotherapy-induced neuropathy and cancer bone pain models.
- Authors: Stine C, Coleman DL, Flohrschutz AT, Thompson AL, Mishra S, Blagg BS, Largent-Milnes TM, Lei W, Streicher JM
- Issue date: 2020 Aug
- Tissue plasminogen activator contributes to morphine tolerance and induces mechanical allodynia via astrocytic IL-1β and ERK signaling in the spinal cord of mice.
- Authors: Berta T, Liu YC, Xu ZZ, Ji RR
- Issue date: 2013 Sep 5